Literature DB >> 19632062

Spinal and paraspinal Ewing tumors.

Daniel J Indelicato1, Sameer R Keole, Amir H Shahlaee, Christopher G Morris, C Parker Gibbs, Mark T Scarborough, David W Pincus, Robert B Marcus.   

Abstract

PURPOSE: To perform a review of the 40-year University of Florida experience treating spinal and paraspinal Ewing tumors. PATIENTS AND METHODS: A total of 27 patients were treated between 1965 and 2007. For local management, 21 patients were treated with radiotherapy (RT) alone and 6 with surgery plus RT. All patients with metastatic disease were treated with RT alone. The risk profiles of each group were otherwise similar. The median age was 17 years, and the most frequent subsite was the sacral spine (n = 9). The median potential follow-up was 16 years.
RESULTS: The 5-year actuarial overall survival, cause-specific survival, and local control rate was 62%, 62%, and 90%, respectively. For the nonmetastatic subset (n = 22), the 5-year overall survival, cause-specific survival, and local control rate was 71%, 71%, and 89%, respectively. The local control rate was 84% for patients treated with RT alone vs. 100% for those treated with surgery plus RT. Patients who were >14 years old and those who were treated with intensive therapy demonstrated superior local control. Of 9 patients in our series with Frankel C or greater neurologic deficits at presentation, 7 experienced a full recovery with treatment. Of the 27 patients, 37% experienced Common Toxicity Criteria Grade 3 or greater toxicity, including 2 deaths from sepsis.
CONCLUSION: Aggressive management of spinal and paraspinal Ewing tumors with RT with or without surgery results in high toxicity but excellent local control and neurologic outcomes. Efforts should be focused on identifying disease amenable to combined modality local therapy and improving RT techniques.

Entities:  

Mesh:

Year:  2009        PMID: 19632062     DOI: 10.1016/j.ijrobp.2009.03.042

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

Review 1.  Progress in radiotherapy for pediatric sarcomas.

Authors:  Susan L McGovern; Anita Mahajan
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

2.  Impact of first-line treatment on outcomes of Ewing sarcoma of the spine.

Authors:  Jianjun Zhang; Yujing Huang; Jing Lu; Aina He; Yan Zhou; Haiyan Hu; Zan Shen; Yuanjue Sun; Yang Yao
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

3.  Ewing's Sarcoma of the Cervical Spine.

Authors:  Paul H Dahm; Meenakshi Bhattacharjee; Winston Huh; Vandana Thapar
Journal:  J Pediatr Intensive Care       Date:  2017-08-24

Review 4.  Systematic Review of En Bloc Resection in the Management of Ewing's Sarcoma of the Mobile Spine with Respect to Local Control and Disease-Free Survival.

Authors:  Mathew David Sewell; Kimberly-Anne Tan; Nasir A Quraishi; Corina Preda; Peter P Varga; Richard Williams
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy.

Authors:  Anjani Kumar Jha; Pradeep Neupane; Manohar Pradhan; Krishna Sagar Sharma; Sadina Shrestha; Padma Raj Sigdel; Sigbjørn Smeland; Øyvind S Bruland
Journal:  J Glob Oncol       Date:  2019-03

Review 6.  The Role of Neuroaxis Irradiation in the Treatment of Intraspinal Ewing Sarcoma: A Review and Meta-Analysis.

Authors:  Fabian M Troschel; Kai Kröger; Jan J Siats; Kambiz Rahbar; Hans Theodor Eich; Sergiu Scobioala
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

7.  Multidisciplinary Management of Primary Sacral Tumors: A Tertiary Care Center's Experience and Literature Review.

Authors:  Venugopal Sarath Chander; Ramachandran Govindasamy; Venkata Ramakrishna Tukkapuram; Swaroop Gopal; Satish Rudrappa
Journal:  Asian Spine J       Date:  2021-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.